![Biotechnology / Medicine / Glycoproteins / Monoclonal antibody therapy / Monoclonal antibodies / Merck & Co. / Biologic / Antibody / Symphogen / Biology / Immune system / Immunology Biotechnology / Medicine / Glycoproteins / Monoclonal antibody therapy / Monoclonal antibodies / Merck & Co. / Biologic / Antibody / Symphogen / Biology / Immune system / Immunology](https://www.pdfsearch.io/img/2f56483ad16ca0aed4ecfec61625f716.jpg)
| Document Date: 2014-12-09 09:56:32 Open Document File Size: 299,00 KBShare Result on Facebook
City Vancouver / / Company Merck & Co. Inc. / Zymeworks Inc. / Merck / / Country United States / Canada / / Event Business Partnership / / IndustryTerm treatment of oncology / autoimmunity and inflammatory diseases / protein engineering technology / / MedicalCondition inflammatory diseases / / Person Ali Tehrani / / Position President & CEO / / Product ZymeCAD / / ProvinceOrState British Columbia / / Technology protein engineering technology / antibodies / drug development / / URL www.zymeworks.com / /
SocialTag |